Home Cart Sign in  
Chemical Structure| 126150-97-8 Chemical Structure| 126150-97-8

Structure of BAPTA-AM
CAS No.: 126150-97-8

Chemical Structure| 126150-97-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAPTA-AM is a well-known membrane-permeable Ca2+ chelator that inhibits hERG channels, hKv1.3, and hKv1.5 channels in HEK 293 cells with IC50 values of 1.3 μM, 1.45 μM, and 1.23 μM, respectively.

Synonyms: BAPTA Acetoxymethyl ester

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BAPTA-AM

CAS No. :126150-97-8
Formula : C34H40N2O18
M.W : 764.68
SMILES Code : O=C(OCOC(C)=O)CN(CC(OCOC(C)=O)=O)C1=CC=CC=C1OCCOC2=CC=CC=C2N(CC(OCOC(C)=O)=O)CC(OCOC(C)=O)=O
Synonyms :
BAPTA Acetoxymethyl ester
MDL No. :MFCD00036696
InChI Key :YJIYWYAMZFVECX-UHFFFAOYSA-N
Pubchem ID :2293

Safety of BAPTA-AM

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 cells 10 μM 24 hours To investigate the effect of BAPTA-AM on L687-mediated ASO uptake, the results showed that BAPTA-AM significantly suppressed L687-mediated ASO uptake, indicating that Ca2+ influx via TRPC3/C6 channels is critical for L687-mediated increased ASO uptake. PMC11109983
AML-12 cells 200 ng/mL 12 hours By clearing excess intracellular Ca2+, mitochondrial function was restored, promoting the generation of endogenous NAD+. PMC10190643
HK-2 cells 200 ng/mL 12 hours By clearing excess intracellular Ca2+, intracellular calcium homeostasis was restored, reducing cell apoptosis. PMC10190643
MCF-7 cells 50 μM 15 minutes BAPTA-AM effectively inhibited the TG-induced increase in intracellular calcium, thereby inhibiting EV biogenesis. PMC7067202
hCMEC-D3 cells 50 μM 18 hours BAPTA-AM inhibited the A23187-induced increase in calcium, thereby inhibiting EV biogenesis. PMC7067202
HeLa cells 20 μM 6 hours BAPTA-AM completely blocked m-3M3FBS-induced cell death, confirming the role of intracellular calcium overload in cell death. PMC9287385
SKOV3 cells 20 μM 12 hours Treatment with BAPTA-AM significantly reduced the migration, invasion, and wound healing of SKOV3 cells and mitigated the IGF-induced migration, invasion, and wound healing. PMC6396458
OVCAR3 cells 20 μM 12 hours Treatment with BAPTA-AM significantly reduced the migration, invasion, and wound healing of OVCAR3 cells and mitigated the IGF-induced migration, invasion, and wound healing. PMC6396458
SH-SY5Y human neuroblastoma cells 10 or 20 μM 30 minutes To investigate the effect of BAPTA-AM on Cd-induced intracellular Ca2+ concentration, results showed that pretreatment with BAPTA-AM significantly inhibited the Cd-induced increase in intracellular Ca2+ concentration. PMC5848555

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice LPS-induced sepsis model intravenous injection 0.1, 0.3, 1 mg/kg administered at 0, 24, and 48 hours By clearing excess Ca2+, intracellular calcium homeostasis was restored, inhibiting cell apoptosis and ultimately restoring organ function. PMC10190643

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.31mL

0.26mL

0.13mL

6.54mL

1.31mL

0.65mL

13.08mL

2.62mL

1.31mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories